Physician profile
Eric Eisenberg
NPI 1427171545
$377.83
in general payments reported to CMS, 2019-2025
11 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $143 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365 · Education: $12.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.41 |
| Education | $12.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $61.48 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Indivior INC. | $49.39 | 2024-2025 | Sublocade |
| Lilly USA, LLC | $41.19 | 2025 | Mounjaro, Zepbound |
| Gilead Sciences, INC. | $38.88 | 2025 | |
| Biogen, INC. | $38.16 | 2024-2025 | Zurzuvae |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.70 | 2025 | Jardiance |
| Daiichi Sankyo INC. | $29.79 | 2024 | Injectafer |
| Otsuka America Pharmaceutical, INC. | $27.26 | 2024 | Rexulti, Abilify Asimtufii |
| Braeburn INC. | $23.03 | 2024 | Brixadi |
| Axsome Therapeutics, INC. | $17.91 | 2024 | Auvelity |
| Pfizer INC. | $14.04 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Eisenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.